|
Active substance |
Eftrenacog alfa |
|
Holder |
Sobi Belgium |
|
Status |
Closed |
|
Indication |
Treatment and prophylaxis of bleedings in hemophilia B patients (deficiency= Factor IX coagulation factor) |
|
Public documents |
|
|
Last update |
17/01/2018 |
Alprolix®
Last updated on 10/09/2024